Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Visa
V
|
+$55.5M |
| 2 |
Strategy Inc Common Stock Class A
MSTR
|
+$35.4M |
| 3 |
International Paper
IP
|
+$25.3M |
| 4 |
DoorDash
DASH
|
+$21.9M |
| 5 |
Natera
NTRA
|
+$17.1M |
Top Sells
| 1 |
Chevron
CVX
|
+$712M |
| 2 |
Apple
AAPL
|
+$120M |
| 3 |
Interactive Brokers
IBKR
|
+$38.1M |
| 4 |
NVIDIA
NVDA
|
+$24.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$23.8M |
Sector Composition
| 1 | Technology | 31.47% |
| 2 | Healthcare | 11.82% |
| 3 | Consumer Discretionary | 11.72% |
| 4 | Communication Services | 9.55% |
| 5 | Industrials | 9.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1351
FormFactor
FORM
$2.76B
| $4.25M | ﹤0.01% |
150,100
-2,100
| -1% | -$59.4K |
|
1352
Interparfums
IPAR
$3.35B
| $4.24M | ﹤0.01% |
37,200
-400
| -1% | -$45.5K |
|
1353
Mercury Systems
MRCY
$4.58B
| $4.23M | ﹤0.01% |
98,200
-1,300
| -1% | -$56K |
|
1354
Klaviyo
KVYO
$10.2B
| $4.23M | ﹤0.01% |
139,800
+25,600
| +22% | +$775K |
|
1355
Xenon Pharmaceuticals
XENE
$2.9B
| $4.21M | ﹤0.01% |
125,600
-1,000
| -0.8% | -$33.6K |
|
1356
Polaris
PII
$3.21B
| $4.2M | ﹤0.01% |
102,700
-1,500
| -1% | -$61.4K |
|
1357
Protagonist Therapeutics
PTGX
$3.85B
| $4.2M | ﹤0.01% |
86,900
| – | – |
|
1358
Concentrix
CNXC
$3.6B
| $4.19M | ﹤0.01% |
75,385
-1,100
| -1% | -$61.2K |
|
1359
Columbia Sportswear
COLM
$2.97B
| $4.19M | ﹤0.01% |
55,400
-13,800
| -20% | -$1.04M |
|
1360
Autohome
ATHM
$3.44B
| $4.19M | ﹤0.01% |
151,189
| – | – |
|
1361
Albany International
AIN
$1.7B
| $4.19M | ﹤0.01% |
60,700
-700
| -1% | -$48.3K |
|
1362
ACV Auctions
ACVA
$1.81B
| $4.18M | ﹤0.01% |
296,800
-2,600
| -0.9% | -$36.6K |
|
1363
DigitalOcean
DOCN
$3.38B
| $4.18M | ﹤0.01% |
125,200
-1,500
| -1% | -$50.1K |
|
1364
Renasant Corp
RNST
$3.67B
| $4.18M | ﹤0.01% |
123,200
-1,800
| -1% | -$61.1K |
|
1365
Privia Health
PRVA
$2.76B
| $4.17M | ﹤0.01% |
185,900
-2,200
| -1% | -$49.4K |
|
1366
Teradata
TDC
$2.1B
| $4.17M | ﹤0.01% |
185,359
-3,500
| -2% | -$78.7K |
|
1367
Visteon
VC
$3.49B
| $4.15M | ﹤0.01% |
53,500
-800
| -1% | -$62.1K |
|
1368
Coty
COTY
$3.76B
| $4.15M | ﹤0.01% |
758,401
-9,700
| -1% | -$53.1K |
|
1369
Enovis
ENOV
$1.9B
| $4.14M | ﹤0.01% |
108,300
-1,500
| -1% | -$57.3K |
|
1370
LivaNova
LIVN
$3.04B
| $4.13M | ﹤0.01% |
105,219
-1,600
| -1% | -$62.8K |
|
1371
Boston Beer
SAM
$2.46B
| $4.13M | ﹤0.01% |
17,300
-700
| -4% | -$167K |
|
1372
BlackBerry
BB
$2.49B
| $4.13M | ﹤0.01% |
1,095,650
-13,700
| -1% | -$51.6K |
|
1373
Arcellx
ACLX
$4.38B
| $4.13M | ﹤0.01% |
62,900
-500
| -0.8% | -$32.8K |
|
1374
Provident Financial Services
PFS
$2.63B
| $4.12M | ﹤0.01% |
240,129
-3,600
| -1% | -$61.8K |
|
1375
American Eagle Outfitters
AEO
$3.39B
| $4.11M | ﹤0.01% |
353,600
-5,300
| -1% | -$61.6K |
|